407 related articles for article (PubMed ID: 33685566)
21. Sublingual immunotherapy efficacy in patients with atopic dermatitis and house dust mites sensitivity: a prospective pilot study.
Cadario G; Galluccio AG; Pezza M; Appino A; Milani M; Pecora S; Mastrandrea F
Curr Med Res Opin; 2007 Oct; 23(10):2503-6. PubMed ID: 17784996
[TBL] [Abstract][Full Text] [Related]
22. Fast onset of action of sublingual immunotherapy in house dust mite-induced allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial.
Wang DH; Chen L; Cheng L; Li KN; Yuan H; Lu JH; Li H
Laryngoscope; 2013 Jun; 123(6):1334-40. PubMed ID: 23616386
[TBL] [Abstract][Full Text] [Related]
23. Absence of IgE neosensitization in house dust mite allergic patients following sublingual immunotherapy.
Baron-Bodo V; Batard T; Nguyen H; Fréreux M; Horiot S; Harwanegg C; Bergmann KC; de Beaumont O; Moingeon P
Clin Exp Allergy; 2012 Oct; 42(10):1510-8. PubMed ID: 22994348
[TBL] [Abstract][Full Text] [Related]
24. Semi-depot house-dust mite allergen extract for Chinese with allergic rhinitis and asthma.
Li X; Wang X; Lin X; Xu G; Tao Z; Jiang W; Cheng L; Guo Y; Lai H; Shen K
Am J Rhinol Allergy; 2016 May; 30(3):201-8. PubMed ID: 27216351
[TBL] [Abstract][Full Text] [Related]
25. Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multi-centre, randomized, dose-response study.
Werfel T; Breuer K; Ruéff F; Przybilla B; Worm M; Grewe M; Ruzicka T; Brehler R; Wolf H; Schnitker J; Kapp A
Allergy; 2006 Feb; 61(2):202-5. PubMed ID: 16409197
[TBL] [Abstract][Full Text] [Related]
26. Effect of Cluster Allergen-Specific Immunotherapy in Patients with Atopic Dermatitis Sensitive to House Dust Mite.
Elazab SZ; Hessam WF; Gomaa AH
Egypt J Immunol; 2018 Jun; 25(2):97-106. PubMed ID: 30600952
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of sensitization to the crude extract of Dermatophagoides farinae and its derived allergens, Der f 2 and Zen 1, in dogs with atopic dermatitis in Southern Brazil.
Ludwig L; Tsukui T; Kageyama M; Farias M
Vet Immunol Immunopathol; 2021 Apr; 234():110199. PubMed ID: 33662650
[TBL] [Abstract][Full Text] [Related]
28. [The impact of subcutaneous immunotherapy with Dermatophagoides farinae and Dermatophagoides pteronyssinus on the quality of life of patients with allergic rhinitis and asthma].
Yepes-Núñez JJ; Gómez C; Espinoza Y; Cardona R
Biomedica; 2014; 34(2):282-90. PubMed ID: 24967933
[TBL] [Abstract][Full Text] [Related]
29. [Specific immunotherapy in the treatment of patients with atopic dermatitis--results of double blind placebo controlled study].
Silny W; Czarnecka-Operacz M
Pol Merkur Lekarski; 2006 Dec; 21(126):558-65. PubMed ID: 17405298
[TBL] [Abstract][Full Text] [Related]
30. Treatment of severe atopic dermatitis with a combination of subcutaneous allergen immunotherapy and cyclosporin.
Nahm DH; Kim ME
Yonsei Med J; 2012 Jan; 53(1):158-63. PubMed ID: 22187247
[TBL] [Abstract][Full Text] [Related]
31. House dust mite SCIT reduces asthma risk and significantly improves long-term rhinitis and asthma control-A RWE study.
Jutel M; Klimek L; Richter H; Brüggenjürgen B; Vogelberg C
Allergy; 2024 Apr; 79(4):1042-1051. PubMed ID: 38429981
[TBL] [Abstract][Full Text] [Related]
32. Proof of concept of the preventive efficacy of high-dose recombinant mono-allergen immunotherapy in atopic dogs sensitized to the Dermatophagoides farinae allergen Der f 2.
Olivry T; Paps JS; Dunston SM
Vet Dermatol; 2017 Apr; 28(2):183-e40. PubMed ID: 28261915
[TBL] [Abstract][Full Text] [Related]
33. Double-blind placebo-controlled house dust mite control measures in adult patients with atopic dermatitis.
Gutgesell C; Heise S; Seubert S; Seubert A; Domhof S; Brunner E; Neumann C
Br J Dermatol; 2001 Jul; 145(1):70-4. PubMed ID: 11453909
[TBL] [Abstract][Full Text] [Related]
34. Successful transdermal allergen delivery and allergen-specific immunotherapy using biodegradable microneedle patches.
Kim JH; Shin JU; Kim SH; Noh JY; Kim HR; Lee J; Chu H; Jeong KY; Park KH; Kim JD; Kim HK; Jeong DH; Yong TS; Park JW; Lee KH
Biomaterials; 2018 Jan; 150():38-48. PubMed ID: 29032329
[TBL] [Abstract][Full Text] [Related]
35. Correlation of skin test results and specific immunoglobulin E blood levels with nasal provocation testing for house-dust mite allergies.
Haxel BR; Huppertz T; Boessert P; Bast F; Fruth K
Am J Rhinol Allergy; 2016; 30(1):60-4. PubMed ID: 26867532
[TBL] [Abstract][Full Text] [Related]
36. Identification of Robust Biomarkers for Early Predicting Efficacy of Subcutaneous Immunotherapy in Children With House Dust Mite-Induced Allergic Rhinitis by Multiple Cytokine Profiling.
Xie S; Fan R; Tang Q; Cai X; Zhang H; Wang F; Xie S; Gao K; Zhang J; Xie Z; Jiang W
Front Immunol; 2021; 12():805404. PubMed ID: 35095890
[TBL] [Abstract][Full Text] [Related]
37. Comparison of the long-term efficacy of 3- and 5-year house dust mite allergen immunotherapy.
Stelmach I; Sobocińska A; Majak P; Smejda K; Jerzyńska J; Stelmach W
Ann Allergy Asthma Immunol; 2012 Oct; 109(4):274-8. PubMed ID: 23010234
[TBL] [Abstract][Full Text] [Related]
38. The Differences in Serum Quantitative Specific IgE Levels Induced by Dermatophagoides pteronyssinus, Dermatophagoides farinae and Blomia tropicalis Sensitization in Intermittent and Persistent Allergic Asthma.
Susanto AJ; Rengganis I; Rumende CM; Harimurti K
Acta Med Indones; 2017 Oct; 49(4):299-306. PubMed ID: 29348379
[TBL] [Abstract][Full Text] [Related]
39. Salivary Immunoglobulin A, E, and G4 Levels Specific to Dermatophagoides pteronyssinus in Allergic Rhinitis Patients Treated With Subcutaneous Immunotherapy.
Liu Y; Xing Z; Wang J; Geng C
Am J Rhinol Allergy; 2018 Nov; 32(6):458-464. PubMed ID: 30124065
[TBL] [Abstract][Full Text] [Related]
40. An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies.
Calderon MA; Casale TB; Nelson HS; Demoly P
J Allergy Clin Immunol; 2013 Dec; 132(6):1322-36. PubMed ID: 24139829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
